The sixth Chiang-Chen meeting has concluded on Wednesday, but several civil groups are questioning the recently signed medical and health cooperation agreement. They said that it fails to specify which country's medical standards should be followed regarding clinical testing on new drugs, and China also lacks transparency when it comes to reporting epidemics, which can increase Taiwan's public health risks.

The medical cooperation pact signed during the sixth Chiang-Chen summit is aimed at spurring cross-strait medical development, but civic groups are concerned about the disparity in medical standards between Taiwan and China.

The groups say that China's epidemic reporting lacks transparency, and that China's clinical trials are largely unregulated.

Apart from questioning whether the pact will harm the health and safety of Taiwan's people, the groups say that the pact should be passed by the Legislative Yuan before being promulgated.

They are also calling on the government to uphold the safety and freedom of the Taiwanese business community when a proposed investment protection agreement is signed during the next summit.

Finally, the groups are blasting the new cross-strait economic cooperation commission, saying that the establishment of the commission severely harms Taiwan's constitutional system and democratic value.